Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Lung Cancer

  Free Subscription


Articles published in Clin Nucl Med

Retrieve available abstracts of 44 articles:
HTML format
Text format



Single Articles


    July 2017
  1. GAO R, Gao S, Feng J, Wang Y, et al
    Diffuse Thyroid Metastasis From Lung Cancer Mimicking Thyroiditis on 99mTc-Pertechnetate Scintigraphy.
    Clin Nucl Med. 2017 Jul 6. doi: 10.1097/RLU.0000000000001755.
    PubMed     Text format     Abstract available


    June 2017
  2. VAZ SC, Oliveira C, Castanheira JC, Silva AF, et al
    18F-FDG Uptake in Ischemic Colitis During Follow-up of a Patient With Lung Cancer.
    Clin Nucl Med. 2017 Jun 19. doi: 10.1097/RLU.0000000000001723.
    PubMed     Text format     Abstract available


  3. SOMMERFELDT J, Miao TL, Zuckier LS, Gupta A, et al
    High Prevalence of Pneumothorax on PET-CT Studies Performed in Lung Cancer Patients Following Post-Transthoracic Needle Biopsy Mandates Careful Scrutiny.
    Clin Nucl Med. 2017 Jun 5. doi: 10.1097/RLU.0000000000001716.
    PubMed     Text format     Abstract available


    May 2017
  4. MAPELLI P, Incerti E, Fallanca F, Bettinardi V, et al
    Concomitant Lung Cancer and Gastrointestinal Stromal Tumor: First Report of Hypoxia Imaging With 18F-FAZA PET/CT.
    Clin Nucl Med. 2017 May 19. doi: 10.1097/RLU.0000000000001704.
    PubMed     Text format     Abstract available


  5. GROE HOKAMP N, Kobe C, Linzenich E, Maintz D, et al
    Solitary PSMA-Positive Pulmonary Metastasis in Biochemical Relapse of Prostate Cancer.
    Clin Nucl Med. 2017;42:406-407.
    PubMed     Text format     Abstract available


    April 2017
  6. SAVELLI G, Bna C, Zambelli C, Illuminati S, et al
    An 111In-Pentetreotide Positive Sclerosing Pneumocytoma.
    Clin Nucl Med. 2017;42:282-284.
    PubMed     Text format     Abstract available


    March 2017
  7. JANSSEN I, Wolf KI, Chui CH, Millo CM, et al
    Relevant Discordance Between 68Ga-DOTATATE and 68Ga-DOTANOC in SDHB-Related Metastatic Paraganglioma: Is Affinity to Somatostatin Receptor 2 the Key?
    Clin Nucl Med. 2017;42:211-213.
    PubMed     Text format     Abstract available


    February 2017
  8. FU Z, Liu M, Zhang J, Li Z, et al
    Nasal-Tip Metastasis on 18 F-FDG PET/CT Scan in a Patient With Squamous Lung Carcinoma.
    Clin Nucl Med. 2017 Feb 24. doi: 10.1097/RLU.0000000000001597.
    PubMed     Text format     Abstract available


  9. BAI X, Zhuang H
    Prominent Pulmonary Metastases Without Concurrent Osseous Involvement in Patients With High-Risk Neuroblastoma.
    Clin Nucl Med. 2017 Feb 13. doi: 10.1097/RLU.0000000000001579.
    PubMed     Text format     Abstract available


    January 2017
  10. ABUBAKAR S, Amoako YA, Kotze T, Tag N, et al
    Source of Ectopic ACTH Secretion Easily Identified by 68Ga DOTANOC PET/CT.
    Clin Nucl Med. 2017 Jan 16. doi: 10.1097/RLU.0000000000001541.
    PubMed     Text format     Abstract available


    December 2016
  11. VADRUCCI M, Gilardi L, Crivelli F, Baroli A, et al
    18F-FDG PET/CT in Metastatic Pilomatrix Carcinoma.
    Clin Nucl Med. 2016;41:e525-e526.
    PubMed     Text format     Abstract available


  12. PANAGIOTIDIS E, Seshadri N, Fernando R, Healey P, et al
    68Ga-DOTANOC Focal Pulmonary Activity With No Corresponding CT Abnormality.
    Clin Nucl Med. 2016;41:948-950.
    PubMed     Text format     Abstract available


  13. LI W, Li W, Zhang R
    Metastasis to the Medial Cuneiform Bone from Squamous Cell Carcinoma of the Lung Revealed by Bone Scintigraphy.
    Clin Nucl Med. 2016;41:946-947.
    PubMed     Text format     Abstract available


    October 2016
  14. HSU J, Jia L, Pucar D, Williams H, et al
    Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia and Granulomatous Inflammation Mimicking High-Grade Malignancy on FDG-PET/CT.
    Clin Nucl Med. 2016.
    PubMed     Text format     Abstract available


  15. QUTBI M, Shafeie B, Amoui M, Tabeie F, et al
    Evaluation of Prognostic Factors Associated With Differentiated Thyroid Carcinoma With Pulmonary Metastasis.
    Clin Nucl Med. 2016.
    PubMed     Text format     Abstract available


  16. KHOO AC, Hamzah F, Ong CK
    Incidental Sclerosing Pneumocytoma Detected on Bone Scintigraphy.
    Clin Nucl Med. 2016.
    PubMed     Text format     Abstract available


  17. SHETTY D, Loh H, Bui C, Mansberg R, et al
    Non-Prostate-Specific Membrane Antigen-Avid Metastatic Lung Nodule From Primary Prostatic Adenocarcinoma.
    Clin Nucl Med. 2016;41:776-8.
    PubMed     Text format     Abstract available


    September 2016
  18. MAYERHOEFER ME, Karanikas G, Kletter K, Kiesewetter B, et al
    Can Interim 18F-FDG PET or Diffusion-Weighted MRI Predict End-of-Treatment Outcome in FDG-Avid MALT Lymphoma After Rituximab-Based Therapy?: A Preliminary Study in 15 Patients.
    Clin Nucl Med. 2016.
    PubMed     Text format     Abstract available


  19. DEJUST S, Morland D, Fabre G, Prevost A, et al
    18F-FDG PET/CT Evaluation of Ceritinib Therapy in Metastatic ALK-Positive Non-small Cell Lung Cancer.
    Clin Nucl Med. 2016.
    PubMed     Text format     Abstract available


  20. CRESPO-JARA A, Gonzalez Manzano R, Lopera Sierra M, Redal Pena MC, et al
    A Patient With Metastatic Sarcoma was Successfully Treated With Radiolabeled Somatostatin Analogs.
    Clin Nucl Med. 2016;41:705-7.
    PubMed     Text format     Abstract available


    August 2016
  21. CHEN YR, Kuo YC, Hsu CN, Hsieh TC, et al
    False Suggestion of Malignant Transformation of Benign Bone Tumor by 18F-FDG PET/CT: A Potential Pitfall.
    Clin Nucl Med. 2016.
    PubMed     Text format     Abstract available


    July 2016
  22. HUNG TJ, Macdonald W, Muir T, Celliers L, et al
    68Ga DOTATATE PET/CT of Non-FDG-Avid Pulmonary Metastatic Hemangiopericytoma.
    Clin Nucl Med. 2016.
    PubMed     Text format     Abstract available


  23. ZHENG N, Bai X, Niu R, Wang X, et al
    Primary Pulmonary Mucinous Adenocarcinoma Was Better Visualized on Delayed FDG PET/CT Imaging.
    Clin Nucl Med. 2016.
    PubMed     Text format     Abstract available


    June 2016
  24. DO VALE RH, Queiroz MA, Coutinho AM, Buchpiguel CA, et al
    18F-FDG PET/CT Osteometabolic Activity in Metastatic Parathyroid Carcinoma.
    Clin Nucl Med. 2016.
    PubMed     Text format     Abstract available


  25. LUTJE S, Sauerwein W, Lauenstein T, Bockisch A, et al
    In Vivo Visualization of Prostate-Specific Membrane Antigen in Adenoid Cystic Carcinoma of the Salivary Gland.
    Clin Nucl Med. 2016;41:476-7.
    PubMed     Text format     Abstract available


    May 2016
  26. LI B, Zhang Y, Hou J, Yu H, et al
    Primary Liver Carcinosarcoma and 18F-FDG PET/CT.
    Clin Nucl Med. 2016.
    PubMed     Text format     Abstract available


  27. OLDAN JD, Chin BB
    FDG PET/CT Imaging of Prostate Carcinosarcoma.
    Clin Nucl Med. 2016.
    PubMed     Text format     Abstract available


  28. SALGARELLO M, Lunardi G, Inno A, Pasetto S, et al
    18F-NaF PET/CT Imaging of Brain Metastases.
    Clin Nucl Med. 2016.
    PubMed     Text format     Abstract available


    April 2016
  29. WANG S, Li M, Chen H, Li J, et al
    FDG PET/CT in Hepatoid Adenocarcinoma of the Lung.
    Clin Nucl Med. 2016.
    PubMed     Text format     Abstract available


  30. CHENG G
    A Case of Lung Squamous Cell Carcinoma With Duodenal Metastasis on FDG PET/CT.
    Clin Nucl Med. 2016.
    PubMed     Text format     Abstract available


    February 2016
  31. WU F, Wang Z, Xing X, Yu M, et al
    The Value of 18F-FDG PET/CT in Diagnostic Procedure of Intravascular Large B-Cell Lymphoma Presenting Fever of Unknown Origin and Pulmonary Hypertension as an Initial Manifestation.
    Clin Nucl Med. 2016.
    PubMed     Text format     Abstract available


    January 2016
  32. SHETTY D, Loh H, Bui C, Mansberg R, et al
    Elevated 68Ga Prostate-Specific Membrane Antigen Activity in Metastatic Non-Small Cell Lung Cancer.
    Clin Nucl Med. 2016.
    PubMed     Text format     Abstract available


  33. UHLEN N, Grundberg O, Jacobsson H, Sundin A, et al
    18F-FDG PET/CT Diagnosis of Bronchopulmonary Carcinoids Versus Pulmonary Hamartomas.
    Clin Nucl Med. 2016.
    PubMed     Text format     Abstract available


  34. LEE JW, Lee SM, Yun M, Cho A, et al
    Prognostic Value of Volumetric Parameters on Staging and Posttreatment FDG PET/CT in Patients With Stage IV Non-Small Cell Lung Cancer.
    Clin Nucl Med. 2016.
    PubMed     Text format     Abstract available


  35. DERLIN T, Jonigk D, Bauersachs J, Bengel FM, et al
    Molecular Imaging of Chemokine Receptor CXCR4 in Non-Small Cell Lung Cancer Using 68Ga-Pentixafor PET/CT: Comparison With 18F-FDG.
    Clin Nucl Med. 2016.
    PubMed     Text format     Abstract available


    November 2015
  36. ERHAMAMCI S, Reyhan M, Canpolat T, Nursal GN, et al
    A Case of a Man With Isolated Breast Metastasis From Lung Adenocarcinoma Incidentally Detected by FDG PET/CT.
    Clin Nucl Med. 2015.
    PubMed     Text format     Abstract available


  37. GUO Y, Wang T, Yang M
    Pulmonary Artery Sarcoma Detected on 18F-FDG PET/CT With Unusual Findings.
    Clin Nucl Med. 2015;40:e530-1.
    PubMed     Text format     Abstract available


    October 2015
  38. NOUGARET S, Ragucci M, Bach AM, Carollo G, et al
    Incidental Detection of Femoral Pseudoaneurysm at 18F-FDG PET/CT.
    Clin Nucl Med. 2015.
    PubMed     Text format     Abstract available


  39. ZHANG L, Zhang X, Zhang R, Fan W, et al
    18F-FDG PET/CT Metabolic Activity in a Patient With Solitary Extramedullary Plasmacytoma of the Lung.
    Clin Nucl Med. 2015.
    PubMed     Text format     Abstract available


    September 2015
  40. JIANG L, Chen S, Li Y, Chen G, et al
    Primary Tracheal and Bronchial Lymphoma Displayed on 18F-FDG PET/CT Imaging.
    Clin Nucl Med. 2015.
    PubMed     Text format     Abstract available


    July 2015
  41. TATCI E, Gokcek A, Unsal E, Cimen F, et al
    FDG PET/CT Findings of Recurrent Respiratory Papillomatosis With Malignant Degeneration in the Lung.
    Clin Nucl Med. 2015.
    PubMed     Text format     Abstract available


    June 2015
  42. HO TY, Chou PC, Yang CT, Tsang NM, et al
    Total lesion glycolysis determined per RECIST 1.1 criteria predicts survival in EGFR mutation-negative patients with advanced lung adenocarcinoma.
    Clin Nucl Med. 2015;40:e295-9.
    PubMed     Text format     Abstract available


  43. BAI X, Yang H, Zhuang H
    Asymmetric thoracic metaiodobenzylguanidine (MIBG) activity due to prior radiation therapy.
    Clin Nucl Med. 2015;40:e338-40.
    PubMed     Text format     Abstract available


    February 2015
  44. PALARD X, Carai S, Le Roux PY, Salaun PY, et al
    Asymmetric Muscle Activity on 18F-FDG PET/CT.
    Clin Nucl Med. 2015.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: